{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:16:38Z","timestamp":1775708198769,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10046-2","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:37:59Z","timestamp":1750286279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ADT increases prostate cancer cell invasion via altering AR\/SALL4\/SOX2-OCT4 stem cell signaling"],"prefix":"10.1007","volume":"41","author":[{"given":"Changcheng","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimaitiaji.","family":"Kadier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"11","key":"10046_CR1","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","volume":"371","author":"ES Antonarakis","year":"2014","unstructured":"Antonarakis ES, Lu C, Wang H, et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med. 2014;371(11):1028\u201338.","journal-title":"N Engl J Med"},{"issue":"32","key":"10046_CR2","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1200\/JCO.19.00799","volume":"37","author":"AJ Armstrong","year":"2019","unstructured":"Armstrong AJ, Szmulewitz RZ, Petrylak DP, et al. ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer. J Clin Oncol. 2019;37(32):2974\u201386.","journal-title":"J Clin Oncol"},{"issue":"7504","key":"10046_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature13229","volume":"510","author":"IA Asangani","year":"2014","unstructured":"Asangani IA, Dommeti VL, Wang X, et al. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature. 2014;510(7504):278\u201382.","journal-title":"Nature"},{"issue":"4\u20135","key":"10046_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.semcdb.2005.03.007","volume":"16","author":"H Axelson","year":"2005","unstructured":"Axelson H, Fredlund E, Ovenberger M, et al. Hypoxia-induced dedifferentiation of tumor cells\u2013a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol. 2005;16(4\u20135):554\u201363.","journal-title":"Semin Cell Dev Biol"},{"issue":"49","key":"10046_CR5","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1038\/s41388-020-01493-8","volume":"39","author":"D Bhagirath","year":"2020","unstructured":"Bhagirath D, Liston M, Patel N, et al. MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer. Oncogene. 2020;39(49):7209\u201323.","journal-title":"Oncogene"},{"issue":"8","key":"10046_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrc1912","volume":"6","author":"C Boccaccio","year":"2006","unstructured":"Boccaccio C, Comoglio PM. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer. 2006;6(8):637\u201345.","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"10046_CR7","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1158\/1078-0432.CCR-20-3471","volume":"27","author":"LC Brown","year":"2021","unstructured":"Brown LC, Halabi S, Schonhoft JD, et al. Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide. Clin Cancer Res. 2021;27(14):4077\u201388.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10046_CR8","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/PAS.0b013e3181a13eef","volume":"33","author":"D Cao","year":"2009","unstructured":"Cao D, Li J, Guo CC, et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol. 2009a;33(7):1065\u201377.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10046_CR9","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/PAS.0b013e318198177d","volume":"33","author":"D Cao","year":"2009","unstructured":"Cao D, Guo S, Allan RW, et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol. 2009b;33(6):894\u2013904.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10046_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.coph.2008.07.005","volume":"8","author":"Y Chen","year":"2008","unstructured":"Chen Y, Sawyers CL, Scher HI. Targeting the androgen receptor pathway in prostate cancer. Curr Opin Pharmacol. 2008;8(4):440\u20138.","journal-title":"Curr Opin Pharmacol"},{"issue":"7297","key":"10046_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature09075","volume":"465","author":"L Chen","year":"2010","unstructured":"Chen L, Park SM, Tumanov AV, et al. CD95 promotes tumour growth. Nature. 2010;465(7297):492\u20136.","journal-title":"Nature"},{"issue":"1","key":"10046_CR12","first-page":"55","volume":"18","author":"C Chen","year":"2015","unstructured":"Chen C, Meng F, Wan H, et al. Interaction between microRNAs and OCT4. Zhongguo Fei Ai Za Zhi. 2015;18(1):55\u20138.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"2","key":"10046_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/pros.24448","volume":"83","author":"S Cheng","year":"2023","unstructured":"Cheng S, Yu X. CTPC, a combined transcriptome data set of human prostate cancer cell lines. Prostate. 2023;83(2):158\u201361.","journal-title":"Prostate"},{"issue":"7","key":"10046_CR14","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1038\/s41418-021-00743-w","volume":"28","author":"G Deng","year":"2021","unstructured":"Deng G, Wang R, Sun Y, et al. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR\/circRNA-ARC1\/miR-125b-2-3p or miR-4736\/PPARgamma\/MMP-9 signals. Cell Death Differ. 2021;28(7):2145\u201359.","journal-title":"Cell Death Differ"},{"issue":"3","key":"10046_CR15","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/sj.bjc.6601127","volume":"89","author":"J Edwards","year":"2003","unstructured":"Edwards J, Krishna NS, Grigor KM, et al. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer. 2003;89(3):552\u20136.","journal-title":"Br J Cancer"},{"issue":"2","key":"10046_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/jop.12335","volume":"45","author":"TY Fu","year":"2016","unstructured":"Fu TY, Hsieh IC, Cheng JT, et al. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression. J Oral Pathol Med. 2016;45(2):89\u201395.","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"10046_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1158\/0008-5472.CAN-20-2588","volume":"81","author":"M Hagiwara","year":"2021","unstructured":"Hagiwara M, Yasumizu Y, Yamashita N, et al. MUC1-C Activates the BAF (mSWI\/SNF) Complex in Prostate Cancer Stem Cells. Cancer Res. 2021;81(4):1111\u201322.","journal-title":"Cancer Res"},{"issue":"1","key":"10046_CR18","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41467-021-21860-7","volume":"12","author":"Y He","year":"2021","unstructured":"He Y, Wei T, Ye Z, et al. A noncanonical AR addiction drives enzalutamide resistance in prostate cancer. Nat Commun. 2021;12(1):1521.","journal-title":"Nat Commun"},{"issue":"4","key":"10046_CR19","doi-asserted-by":"publisher","first-page":"e18372","DOI":"10.1371\/journal.pone.0018372","volume":"6","author":"HW Jeong","year":"2011","unstructured":"Jeong HW, Cui W, Yang Y, et al. SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes. PLoS ONE. 2011;6(4):e18372.","journal-title":"PLoS ONE"},{"issue":"26","key":"10046_CR20","doi-asserted-by":"publisher","first-page":"22361","DOI":"10.18632\/oncotarget.4293","volume":"6","author":"N Kawamura","year":"2015","unstructured":"Kawamura N, Nimura K, Nagano H, et al. CRISPR\/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells. Oncotarget. 2015;6(26):22361\u201374.","journal-title":"Oncotarget"},{"issue":"6","key":"10046_CR21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.cell.2008.02.039","volume":"132","author":"J Kim","year":"2008","unstructured":"Kim J, Chu J, Shen X, et al. An extended transcriptional network for pluripotency of embryonic stem cells. Cell. 2008;132(6):1049\u201361.","journal-title":"Cell"},{"issue":"3","key":"10046_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1006\/geno.1996.0631","volume":"38","author":"J Kohlhase","year":"1996","unstructured":"Kohlhase J, Schuh R, Dowe G, et al. Isolation, characterization, and organ-specific expression of two novel human zinc finger genes related to the Drosophila gene spalt. Genomics. 1996;38(3):291\u20138.","journal-title":"Genomics"},{"issue":"1","key":"10046_CR23","doi-asserted-by":"publisher","first-page":"e53701","DOI":"10.1371\/journal.pone.0053701","volume":"8","author":"S Kregel","year":"2013","unstructured":"Kregel S, Kiriluk KJ, Rosen AM, et al. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer. PLoS ONE. 2013;8(1):e53701.","journal-title":"PLoS ONE"},{"issue":"1","key":"10046_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jmcb\/mjs042","volume":"5","author":"SO Lee","year":"2013","unstructured":"Lee SO, Ma Z, Yeh CR, et al. New therapy targeting differential androgen receptor signaling in prostate cancer stem\/progenitor vs. non-stem\/progenitor cells. J Mol Cell Biol. 2013;5(1):14\u201326.","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"10046_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13046-021-02147-7","volume":"40","author":"Y Lee","year":"2021","unstructured":"Lee Y, Yoon J, Ko D, et al. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1. J Exp Clin Cancer Res. 2021;40(1):372.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10046_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/onc.2013.529","volume":"34","author":"A Li","year":"2015","unstructured":"Li A, Jiao Y, Yong KJ, et al. SALL4 is a new target in endometrial cancer. Oncogene. 2015;34(1):63\u201372.","journal-title":"Oncogene"},{"key":"10046_CR27","doi-asserted-by":"publisher","first-page":"110000","DOI":"10.1016\/j.compbiomed.2025.110000","volume":"189","author":"L Li","year":"2025","unstructured":"Li L, Cho KH, Yu X, et al. Systematic multi-omics investigation of androgen receptor driven gene expression and epigenetics changes in prostate cancer. Comput Biol Med. 2025;189:110000.","journal-title":"Comput Biol Med"},{"issue":"10","key":"10046_CR28","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1158\/0008-5472.CAN-18-2812","volume":"79","author":"S Li","year":"2019","unstructured":"Li S, Fong KW, Gritsina G, et al. Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. Cancer Res. 2019;79(10):2580\u201392.","journal-title":"Cancer Res"},{"issue":"5","key":"10046_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.stem.2008.08.004","volume":"3","author":"CY Lim","year":"2008","unstructured":"Lim CY, Tam WL, Zhang J, et al. Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell. 2008;3(5):543\u201354.","journal-title":"Cell Stem Cell"},{"issue":"27","key":"10046_CR30","doi-asserted-by":"publisher","first-page":"19359","DOI":"10.1074\/jbc.M113.477216","volume":"288","author":"TH Lin","year":"2013","unstructured":"Lin TH, Lee SO, Niu Y, et al. Differential androgen deprivation therapies with anti-androgens casodex\/bicalutamide or MDV3100\/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis. J Biol Chem. 2013a;288(27):19359\u201369.","journal-title":"J Biol Chem"},{"key":"10046_CR31","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1038\/cddis.2013.270","volume":"4","author":"TH Lin","year":"2013","unstructured":"Lin TH, Izumi K, Lee SO, et al. Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling. Cell Death Dis. 2013b;4:e764.","journal-title":"Cell Death Dis"},{"key":"10046_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2018.02.007","volume":"425","author":"W Lin","year":"2018","unstructured":"Lin W, Luo J, Sun Y, et al. ASC-J9((R)) suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3. Cancer Lett. 2018;425:21\u201330.","journal-title":"Cancer Lett"},{"key":"10046_CR33","doi-asserted-by":"publisher","first-page":"1146849","DOI":"10.3389\/fcell.2023.1146849","volume":"11","author":"R Liu","year":"2023","unstructured":"Liu R, Peng Y, Du W, et al. BMI1 fine-tunes gene repression and activation to safeguard undifferentiated spermatogonia fate. Front Cell Dev Biol. 2023;11:1146849.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"10046_CR34","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1182\/blood-2006-02-001594","volume":"108","author":"Y Ma","year":"2006","unstructured":"Ma Y, Cui W, Yang J, et al. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood. 2006;108(8):2726\u201335.","journal-title":"Blood"},{"issue":"13","key":"10046_CR35","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1158\/0008-5472.CAN-10-3320","volume":"71","author":"J Mathieu","year":"2011","unstructured":"Mathieu J, Zhang Z, Zhou W, et al. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res. 2011;71(13):4640\u201352.","journal-title":"Cancer Res"},{"issue":"10","key":"10046_CR36","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","volume":"14","author":"ME Matyskiela","year":"2018","unstructured":"Matyskiela ME, Couto S, Zheng X, et al. SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. Nat Chem Biol. 2018;14(10):981\u20137.","journal-title":"Nat Chem Biol"},{"issue":"12","key":"10046_CR37","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1038\/modpathol.2009.148","volume":"22","author":"K Mei","year":"2009","unstructured":"Mei K, Liu A, Allan RW, et al. Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases. Mod Pathol. 2009;22(12):1628\u201336.","journal-title":"Mod Pathol"},{"issue":"6","key":"10046_CR38","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cell.2006.01.040","volume":"124","author":"J Moffat","year":"2006","unstructured":"Moffat J, Grueneberg DA, Yang X, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell. 2006;124(6):1283\u201398.","journal-title":"Cell"},{"issue":"5","key":"10046_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12672-014-0190-1","volume":"5","author":"M Nakazawa","year":"2014","unstructured":"Nakazawa M, Antonarakis ES, Luo J. Androgen receptor splice variants in the era of enzalutamide and abiraterone. Horm Cancer. 2014;5(5):265\u201373.","journal-title":"Horm Cancer"},{"issue":"5","key":"10046_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.stemcr.2013.10.001","volume":"1","author":"EJ Paik","year":"2013","unstructured":"Paik EJ, Mahony S, White RM, et al. A Cdx4-Sall4 regulatory module controls the transition from mesoderm formation to embryonic hematopoiesis. Stem Cell Reports. 2013;1(5):425\u201336.","journal-title":"Stem Cell Reports"},{"issue":"4","key":"10046_CR41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molcel.2020.11.046","volume":"81","author":"R Pantier","year":"2021","unstructured":"Pantier R, Chhatbar K, Quante T, et al. SALL4 controls cell fate in response to DNA base composition. Mol Cell. 2021;81(4):845-858e848.","journal-title":"Mol Cell"},{"issue":"10","key":"10046_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nchembio.2131","volume":"12","author":"JA Pollock","year":"2016","unstructured":"Pollock JA, Wardell SE, Parent AA, et al. Inhibiting androgen receptor nuclear entry in castration-resistant prostate cancer. Nat Chem Biol. 2016;12(10):795\u2013801.","journal-title":"Nat Chem Biol."},{"issue":"11","key":"10046_CR43","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1172\/JCI76412","volume":"124","author":"J Qin","year":"2014","unstructured":"Qin J, Lee HJ, Wu SP, et al. Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer. J Clin Invest. 2014;124(11):5013\u201326.","journal-title":"J Clin Invest"},{"issue":"22","key":"10046_CR44","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.1128\/MCB.00419-10","volume":"30","author":"S Rao","year":"2010","unstructured":"Rao S, Zhen S, Roumiantsev S, et al. Differential roles of Sall4 isoforms in embryonic stem cell pluripotency. Mol Cell Biol. 2010;30(22):5364\u201380.","journal-title":"Mol Cell Biol"},{"issue":"13","key":"10046_CR45","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","volume":"367","author":"HI Scher","year":"2012","unstructured":"Scher HI, Fizazi K, Saad F, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med. 2012;367(13):1187\u201397.","journal-title":"N Engl J Med"},{"issue":"3","key":"10046_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"10046_CR47","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/msb.2012.65","volume":"9","author":"MH Tan","year":"2013","unstructured":"Tan MH, Au KF, Leong DE, et al. An Oct4-Sall4-Nanog network controls developmental progression in the pre-implantation mouse embryo. Mol Syst Biol. 2013;9:632.","journal-title":"Mol Syst Biol"},{"issue":"6","key":"10046_CR48","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1053\/j.gastro.2019.08.022","volume":"157","author":"JL Tan","year":"2019","unstructured":"Tan JL, Li F, Yeo JZ, et al. New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation. Gastroenterology. 2019;157(6):1615-1629.e1617.","journal-title":"Gastroenterology"},{"key":"10046_CR49","doi-asserted-by":"crossref","unstructured":"Takayama K, Inoue T, Narita S et al. Castration-induced acceleration of bone metastasis prevented by RANK inhibitor osteoprotegerin in murine castration-resistant prostate cancer model. American Urological Association's 2015 Annual Meeting.\u00a02015;193(4):549\u201350.","DOI":"10.1016\/j.juro.2015.02.1579"},{"issue":"2","key":"10046_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.gene.2016.02.019","volume":"584","author":"H Tatetsu","year":"2016","unstructured":"Tatetsu H, Kong NR, Chong G, et al. SALL4, the missing link between stem cells, development and cancer. Gene. 2016;584(2):111\u20139.","journal-title":"Gene"},{"issue":"4","key":"10046_CR51","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/PAS.0b013e3181d1dcdd","volume":"34","author":"T Ushiku","year":"2010","unstructured":"Ushiku T, Shinozaki A, Shibahara J, et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol. 2010;34(4):533\u201340.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10046_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/bph.15300","volume":"178","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen J, Wu Z, et al. Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021;178(2):239\u201361.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10046_CR53","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1038\/s41467-023-38543-0","volume":"14","author":"B Wang","year":"2023","unstructured":"Wang B, Li C, Ming J, et al. The NuRD complex cooperates with SALL4 to orchestrate reprogramming. Nat Commun. 2023;14(1):2846.","journal-title":"Nat Commun"},{"issue":"12","key":"10046_CR54","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer. 2015;15(12):701\u201311.","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"10046_CR55","doi-asserted-by":"publisher","first-page":"8957","DOI":"10.1128\/JVI.77.16.8957-8951.2003","volume":"77","author":"M Wiznerowicz","year":"2003","unstructured":"Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol. 2003;77(16):8957\u201361.","journal-title":"J Virol"},{"issue":"9","key":"10046_CR56","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.4161\/cc.28418","volume":"13","author":"M Wu","year":"2014","unstructured":"Wu M, Yang F, Ren Z, et al. Identification of the nuclear localization signal of SALL4B, a stem cell transcription factor. Cell Cycle. 2014;13(9):1456\u201362.","journal-title":"Cell Cycle"},{"issue":"50","key":"10046_CR57","doi-asserted-by":"publisher","first-page":"19756","DOI":"10.1073\/pnas.0809321105","volume":"105","author":"J Yang","year":"2008","unstructured":"Yang J, Chai L, Fowles TC, et al. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc Natl Acad Sci U S A. 2008;105(50):19756\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10046_CR58","doi-asserted-by":"publisher","first-page":"e10766","DOI":"10.1371\/journal.pone.0010766","volume":"5","author":"J Yang","year":"2010","unstructured":"Yang J, Gao C, Chai L, et al. A novel SALL4\/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS ONE. 2010;5(5):e10766.","journal-title":"PLoS ONE"},{"issue":"1","key":"10046_CR59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/hep.26956","volume":"60","author":"E Yakaboski","year":"2014","unstructured":"Yakaboski E, Jares A, Ma Y. Stem cell gene SALL4 in aggressive hepatocellular carcinoma: a cancer stem cell-specific target? Hepatology. 2014;60(1):419\u201321.","journal-title":"Hepatology"},{"issue":"6","key":"10046_CR60","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.eururo.2022.08.002","volume":"82","author":"T Yanagisawa","year":"2022","unstructured":"Yanagisawa T, Rajwa P, Thibault C, et al. Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. 2022;82(6):584\u201398.","journal-title":"Eur Urol"},{"issue":"58","key":"10046_CR61","doi-asserted-by":"publisher","first-page":"9392","DOI":"10.1038\/sj.onc.1208311","volume":"23","author":"X Yuan","year":"2004","unstructured":"Yuan X, Curtin J, Xiong Y, et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene. 2004;23(58):9392\u2013400.","journal-title":"Oncogene"},{"issue":"2","key":"10046_CR62","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11060-014-1646-4","volume":"121","author":"L Zhang","year":"2015","unstructured":"Zhang L, Yan Y, Jiang Y, et al. The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome. J Neurooncol. 2015a;121(2):261\u20138.","journal-title":"J Neurooncol"},{"issue":"1","key":"10046_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2014.11.037","volume":"357","author":"X Zhang","year":"2015","unstructured":"Zhang X, Yuan X, Zhu W, et al. SALL4: an emerging cancer biomarker and target. Cancer Lett. 2015b;357(1):55\u201362.","journal-title":"Cancer Lett"},{"issue":"48","key":"10046_CR64","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1038\/onc.2013.495","volume":"33","author":"L Zhang","year":"2014","unstructured":"Zhang L, Xu Z, Xu X, et al. SALL4, a novel marker for human gastric carcinogenesis and metastasis. Oncogene. 2014;33(48):5491\u2013500.","journal-title":"Oncogene"},{"issue":"10","key":"10046_CR65","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/ncb1481","volume":"8","author":"J Zhang","year":"2006","unstructured":"Zhang J, Tam WL, Tong GQ, et al. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol. 2006;8(10):1114\u201323.","journal-title":"Nat Cell Biol"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10046-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10046-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10046-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:03:12Z","timestamp":1750291392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10046-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10046"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10046-2","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed under a protocol approved by the Ethics Committee of Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine (China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}